Table 1 Clinical and demographic characteristics of patients
Entire sample (N = 32) | Stage IV(N = 22) | Stage III(N = 10) | |
|---|---|---|---|
Age (Mean ± SD) | 56.44 ± 10.52 | 55.77 ± 11.10 | 57.90 ± 9.72 |
Males N (%) | 22 (68.8) | 15 (68.2) | 7 (70.0) |
Stage IV Sub-type N (%) | |||
IVa | - | 2 (9.1) | - |
IVb | - | 3 (13.6) | - |
IVc | - | 17 (77.3) | - |
BRAF | |||
Mutated | 11 (34.4) | 7 (31.8) | 4 (40) |
Wild Type | 16 (50) | 14 (63.6) | 2 (20) |
Not Available | 5 (15.6) | 1 (4.5) | 4 (40) |
Length of follow-up in months (Mean ± SD) | 39.28 ± 21.86 | 36.32 ± 24.63 | 45.80 ± 12.73 |